CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
AstraZeneca
Baylor College of Medicine
Affiliated Hospital to Academy of Military Medical Sciences
University of Birmingham
University of Liege